Control method and system of LED light source rhinitis therapeutic apparatus

Abstract

The invention relates to the technical field of light source rhinitis therapeutic apparatuses, and provides a control method and system of an LED light source rhinitis therapeutic apparatus, the rhinitis therapeutic apparatus is powered through a TYPE-C charging port, and the method comprises the steps of obtaining real-time physiological data of tissues in the nasal cavity of a patient, determining light absorption characteristics of the tissues in the nasal cavity, and determining the light absorption characteristics of the tissues in the nasal cavity; carrying out absorbance and transmissivity analysis on the light absorption characteristics to obtain a light power density parameter and a tissue light transmission parameter; and calculating the corresponding illumination duration by using the optical power density parameter, performing light dose correction on the illumination duration based on the tissue light transmission parameter, and controlling the LED irradiation light source after the corrected illumination duration is obtained. By acquiring real-time physiological data of the internal tissue of the nasal cavity of a patient, the treatment effect can be improved, the treatment course can be shortened, power is supplied through the TYPE-C charging port, the size of the equipment is reduced, the portability is improved, and the problems that in the treatment process, the optical power density is low, the treatment course is long, and the portability of the equipment is insufficient are solved.

Description

Technical Field

[0001] The present application relates to the technical field of light source rhinitis therapeutic apparatus, and in particular to a control method and system of an LED light source rhinitis therapeutic apparatus. Background Art

[0002] In modern medicine, rhinitis is a common disease that affects a large number of people. As people's requirements for health and quality of life increase, various rhinitis treatment devices have emerged on the market, using different optical and electrical principles to alleviate patients' symptoms and promote nasal health. In recent years, with the advancement of science and technology, the application of LED light sources in the medical field has gradually become popular. Due to its high efficiency, low energy consumption and diverse spectral characteristics, it has become an emerging means of rhinitis treatment.

[0003] Most rhinitis treatment devices on the market currently use laser light sources for treatment. Although lasers have strong penetrating power and certain therapeutic effects, their optical power density is relatively low, resulting in a longer course of irradiation treatment. In addition, these devices usually use independent power drive control designs, which increases the inconvenience of use and carrying, and limits the user's portability and comfort.

[0004] With respect to the above technical solution, a certain therapeutic effect can be achieved by using laser light source to treat rhinitis in the prior art. However, there are still problems in the treatment process, such as low optical power density, long treatment course and insufficient portability of the equipment. Summary of the invention

[0005] In order to improve the problems of low light power density, long treatment course and insufficient portability of equipment that still exist during the treatment process, the present application provides a control method and system for an LED light source rhinitis therapeutic device.

[0006] The present invention provides a control method for an LED light source rhinitis therapeutic device, which uses a TYPE-C charging port, including: acquiring real-time physiological data of internal tissue of a patient's nasal cavity, determining light absorption characteristics of the nasal cavity tissue according to the real-time physiological data, performing absorbance and transmittance analysis on the light absorption characteristics to obtain light power density parameters and tissue light transmission parameters; calculating corresponding illumination duration using the light power density parameters, performing light dosage correction on the illumination duration based on the tissue light transmission parameters to obtain corrected illumination duration; and controlling the LED irradiation light source of the LED light source rhinitis therapeutic device by using the light power density parameters and the corrected illumination duration.

[0007] As a preferred embodiment, the step of obtaining real-time physiological data of the patient's internal nasal tissue and determining the light absorption characteristics of the nasal tissue based on the real-time physiological data includes: detecting the temperature, humidity and blood oxygen saturation of the internal nasal tissue through a preset physiological data acquisition module to obtain real-time physiological data; wherein the real-time physiological data includes temperature data, humidity data and blood oxygen data; using the temperature data and humidity data, analyzing the physiological condition of the nasal mucosa to obtain mucosal wetness parameters and mucosal congestion degree parameters; combining the mucosal wetness parameters and mucosal congestion degree parameters with the blood oxygen data to obtain light absorption characteristics.

[0008] As a preferred solution, the step of analyzing the absorbance and transmittance of the light absorption characteristics to obtain the light power density parameter and the tissue light transmittance parameter includes: calculating the absorbance and transmittance of the light absorption characteristics for light of different wavelengths; wherein the calculation formula for calculating the absorbance and transmittance of the light absorption characteristics for light of different wavelengths is as follows:

[0009]

[0010] Wherein, A(λ) is the absorbance at wavelength λ, I0(λ) is the incident light intensity, I(λ) is the transmitted light intensity, and T(λ) is the transmittance at wavelength λ; the calculation formula for calculating the optical power density parameter and the tissue light transmittance parameter using the absorbance and the transmittance is as follows:

[0011]

[0012] Among them, P t is the tissue light transmission parameter, P d is the optical power density parameter, P0 is the initial optical power, and S is the spot area.

[0013] As a preferred solution, the calculation formula for calculating the corresponding illumination duration using the optical power density parameter is as follows:

[0014]

[0015] Among them, t0 is the illumination duration, D0 is the target light dose, P d is the light power density parameter, and η is the light dose efficiency parameter.

[0016] As a preferred embodiment, the step of performing light dose correction on the illumination duration based on the tissue light transmission parameters to obtain a corrected illumination duration includes: using the tissue light transmission parameters to calculate the deep light transmission rate and the surface light transmission rate of the nasal tissue, inputting the deep light transmission rate into a preset layered light transmission model for integral calculation to obtain a deep dose distribution parameter; using a light scattering correction method to quantitatively process the surface light transmission rate to obtain a surface dose distribution parameter; correcting the illumination duration according to the deep dose distribution parameters to obtain a preliminary corrected duration, and adjusting the preliminary corrected duration according to the surface dose distribution parameters to obtain a correction factor; and performing a composite calculation of the correction factor and the illumination duration to obtain a corrected illumination duration.

[0017] As a preferred embodiment, the step of adjusting the preliminary correction time according to the surface dose distribution parameters to obtain the correction factor includes: calculating the light energy absorption efficiency and treatment safety parameters of the surface of nasal tissue according to the surface dose distribution parameters, and generating a comprehensive treatment adjustment factor based on the light energy absorption efficiency and treatment safety parameters; adjusting the preliminary correction time according to the comprehensive treatment adjustment factor to obtain the correction factor.

[0018] As a preferred embodiment, the step of controlling the LED irradiation light source of the LED light source rhinitis treatment device through the optical power density parameter and the corrected illumination duration includes: using the optical power density parameter and the corrected illumination duration to set the luminous intensity, wavelength and illumination time of the LED irradiation light source, and using the set LED irradiation light source to illuminate the patient's nasal tissue.

[0019] The present application also provides a control system for an LED light source rhinitis therapeutic device, which uses a TYPE-C charging port and includes: an acquisition unit, used to acquire real-time physiological data of the patient's internal nasal tissue, determine the light absorption characteristics of the nasal tissue based on the real-time physiological data, perform absorbance and transmittance analysis on the light absorption characteristics, and obtain light power density parameters and tissue light transmission parameters; a correction unit, used to calculate the corresponding illumination duration using the light power density parameters, perform light dosage correction on the illumination duration based on the tissue light transmission parameters, and obtain the corrected illumination duration; a control unit, used to control the LED irradiation light source of the LED light source rhinitis therapeutic device through the light power density parameters and the corrected illumination duration.

[0020] Compared with the prior art, the present application has the following beneficial effects: easy to carry and high optical power density. By acquiring the real-time physiological data of the patient's internal nasal tissue in real time, the light absorption characteristics of the nasal tissue can be dynamically analyzed, and the illumination duration can be calculated and corrected according to these characteristics, thereby accurately controlling the irradiation parameters of the LED light source, which can not only improve the treatment effect and shorten the course of treatment, but also be powered through the TYPE-C charging port, which improves the compatibility and charging efficiency of the power supply, reduces the size of the device, improves portability, and improves the problems of low optical power density, long treatment course, and insufficient portability of the device during the treatment process. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0022] The structures, proportions, sizes, etc. illustrated in the drawings of this specification are only used to match the contents disclosed in the specification so as to facilitate understanding and reading by persons familiar with this technology. They are not used to limit the conditions under which the present invention can be implemented, and therefore have no substantive technical significance. Any structural modification, change in proportion or adjustment of size, without affecting the effects and purposes that can be achieved by the present invention, should still fall within the scope of the technical contents disclosed by the present invention.

[0023] Figure 1 It is a flow chart of a control method of an LED light source rhinitis therapeutic device provided by an embodiment of the present invention;

[0024] Figure 2 It is a schematic block diagram of a control system of an LED light source rhinitis therapeutic device provided in an embodiment of the present invention.

[0025] Description of reference numerals:

[0026] 10. Control system of LED light source rhinitis therapeutic device; 11. Acquisition unit; 12. Correction unit; 13. Control unit. DETAILED DESCRIPTION

[0027] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0028] The flowcharts shown in the accompanying drawings are only examples and do not necessarily include all the contents and operations / steps, nor must they be executed in the order described. For example, some operations / steps may also be decomposed, combined or partially merged, so the actual execution order may change according to actual conditions.

[0029] It should also be understood that the terms used in this application specification are only for the purpose of describing specific embodiments and are not intended to limit the application. As used in this application specification and the appended claims, unless the context clearly indicates otherwise, the singular forms "a", "an" and "the" are intended to include plural forms.

[0030] It should be further understood that the term “and / or” used in the specification and appended claims refers to any combination and all possible combinations of one or more of the associated listed items, and includes these combinations.

[0031] The technical solution of the present invention is further described below with reference to the accompanying drawings and through specific implementation methods.

[0032] Embodiment 1:

[0033] like Figure 1 As shown, the present application provides a control method for an LED light source rhinitis therapeutic device, wherein the LED light source rhinitis therapeutic device uses a TYPE-C charging port, and the control method includes steps S100 to S300.

[0034] Step S100, obtaining real-time physiological data of the patient's nasal cavity internal tissue, determining the light absorption characteristics of the nasal cavity tissue based on the real-time physiological data, performing absorbance and transmittance analysis on the light absorption characteristics, and obtaining light power density parameters and tissue light transmittance parameters.

[0035] In this step, the sensor acquires real-time physiological data inside the patient's nasal cavity, including physiological parameters such as blood oxygen saturation, blood flow, and temperature of the nasal tissue. Specifically, the sensor transmits the acquired real-time physiological data to the processor, which calculates the light absorption characteristics of the nasal tissue based on the data, including absorbance and transmittance. Then, through further calculation and analysis, the optical power density parameter and tissue light transmittance parameter are obtained.

[0036] For example, the oxygen absorption capacity of nasal tissue can be determined through blood oxygen saturation data analysis, thereby obtaining the tissue light absorption characteristics; through transmittance analysis, the light transmission efficiency in nasal tissue can be determined, thereby obtaining the light transmission parameters.

[0037] Step S200: Calculate the corresponding illumination duration using the optical power density parameter, perform light dose correction on the illumination duration based on the tissue light transmission parameter, and obtain the corrected illumination duration.

[0038] In this step, the illumination time required to achieve the therapeutic effect is calculated based on the light power density parameters; specifically, the illumination time is preliminarily determined through a preset formula and light power density parameters, and then the preliminarily determined illumination time is corrected using the tissue light transmission parameters to correct the light dose, thereby obtaining an accurate corrected illumination time.

[0039] For example, if the light power density parameter is high, the initially calculated illumination time will be shorter; if the tissue light transmission parameter indicates that the light transmission efficiency is low, the illumination time needs to be extended to ensure that sufficient light dose reaches the nasal tissue.

[0040] Step S300: Control the LED irradiation light source of the LED light source rhinitis treatment device through the light power density parameter and the corrected illumination duration.

[0041] In this step, the brightness and illumination time of the LED light source are adjusted according to the light power density parameter and the corrected illumination duration; specifically, the current and voltage of the LED light source are controlled to achieve a predetermined light power density, and the on and off time of the LED light source is controlled according to the corrected illumination duration.

[0042] For example, if the light power density parameter requires a higher brightness, the current of the LED light source will be increased to improve the light intensity; at the same time, according to the corrected illumination time, the illumination time of the LED light source is set to ensure the treatment effect.

[0043] In this embodiment, by obtaining the real-time physiological data of the patient's internal nasal tissue, the light absorption characteristics of the nasal tissue are determined according to the real-time physiological data, and the absorbance and transmittance are analyzed to obtain the optical power density parameter and the tissue light transmission parameter. Then, the corresponding illumination duration is calculated using the optical power density parameter, and the illumination duration is corrected for light dosage based on the tissue light transmission parameter to obtain the corrected illumination duration. Finally, the LED irradiation light source of the LED light source rhinitis therapeutic device is precisely controlled by the optical power density parameter and the corrected illumination duration. The irradiation parameters of the LED light source are dynamically adjusted according to the real-time physiological data of the patient's internal nasal tissue to ensure the precise matching of the light intensity and duration, thereby improving the treatment effect. Compared with the traditional laser light source treatment method, the use of LED light source not only has a higher optical power density and a shorter treatment cycle, but also can be powered by the Type-C charging port, realizing the miniaturization and portability of the device, greatly improving the convenience of use and carrying, and improving the problems of low optical power density, long treatment course and insufficient portability of the device that still exist during the treatment process.

[0044] Embodiment 2:

[0045] In step S100, the real-time physiological data of the internal tissue of the patient's nasal cavity is obtained, and the light absorption characteristics of the nasal cavity tissue are determined based on the real-time physiological data, including: detecting the temperature, humidity and blood oxygen saturation of the internal tissue of the nasal cavity through a preset physiological data acquisition module to obtain real-time physiological data; wherein the real-time physiological data includes temperature data, humidity data and blood oxygen data.

[0046] The temperature, humidity and blood oxygen saturation inside the patient's nasal cavity are monitored in real time through the sensor module; specifically, the sensor transmits the detected data to the central processing unit, which parses and stores the data to obtain temperature data, humidity data and blood oxygen data.

[0047] For example, the temperature sensor can measure the temperature changes inside the nasal cavity, the humidity sensor can record the humidity conditions in the nasal cavity, and the blood oxygen sensor can measure the blood oxygen saturation level of the nasal tissue.

[0048] The temperature and humidity data are used to analyze the physiological condition of the nasal mucosa, and the mucosal wetness parameters and mucosal congestion degree parameters are obtained.

[0049] By comprehensively analyzing temperature and humidity data, the moisture content and blood flow of the nasal mucosa are evaluated. Specifically, the moistness parameters and congestion parameters of the mucosa are calculated through an algorithm to reflect the health status of the nasal mucosa.

[0050] For example, higher humidity data and lower temperature data indicate higher mucosal moistness, while increased temperature and decreased humidity mean higher mucosal congestion.

[0051] The mucosal wetness parameters and mucosal congestion parameters are combined with the blood oxygen data to obtain the light absorption characteristics.

[0052] The light absorption characteristics of nasal tissue are determined by integrating and analyzing mucosal wetness parameters, mucosal congestion parameters and blood oxygen data; specifically, the above parameters are input into the light absorption model using data fusion technology to calculate the light absorption coefficient of the tissue.

[0053] For example, combining blood oxygen data can calibrate the effects of humidity and congestion to obtain more accurate light absorption characteristics.

[0054] In step S100, the step of analyzing the absorbance and transmittance of the light absorption characteristics to obtain the light power density parameter and the tissue light transmittance parameter includes: calculating the absorbance and transmittance of the light absorption characteristics for light of different wavelengths; wherein the calculation formula for calculating the absorbance and transmittance of the light absorption characteristics for light of different wavelengths is as follows:

[0055]

[0056] Where A(λ) is the absorbance at wavelength λ, I0(λ) is the incident light intensity, I(λ) is the transmitted light intensity, and T(λ) is the transmittance at wavelength λ.

[0057] By substituting the light absorption characteristic data into the calculation formula, the absorbance and transmittance of light of different wavelengths in the tissue are analyzed; specifically, the absorbance and transmittance of each wavelength of light are calculated using the formulas A(λ) and T(λ), respectively, to obtain detailed light absorption characteristic data.

[0058] For example, for red light with a wavelength of 630nm, when the input light intensity I0(λ) is 100mW, the measured transmitted light intensity I(λ) is 50mW, then the calculated absorbance A(λ) and transmittance T(λ) are 0.3010 and 50% respectively.

[0059] The calculation formulas for calculating the optical power density parameters and tissue light transmission parameters using absorbance and transmittance are as follows:

[0060]

[0061] Among them, P t is the tissue light transmission parameter, P d is the optical power density parameter, P0 is the initial optical power, and s is the spot area.

[0062] By using the above formula, the absorbance and transmittance are converted into optical power density parameters and tissue light transmission parameters; specifically, the initial optical power P0 and the spot area S are input, and the required P d and P t .

[0063] For example, if the initial optical power P0 is 200mW and the spot area S is 2cm 2 , the absorbance A(λ) is 0.3010, the transmittance T(λ) is 50%, then the optical power density parameter P d and tissue light transmission parameter P t 30.1mW / cm 2 and 49.95mW / cm 2 .

[0064] In step S200, the calculation formula for calculating the corresponding illumination duration using the optical power density parameter is as follows:

[0065]

[0066] Among them, t0 is the illumination duration, D0 is the target light dose, P d is the light power density parameter, and η is the light dose efficiency parameter.

[0067] The light exposure time required for treatment is calculated by the light power density parameter; specifically, the target light dose D0 and the light power density parameter P d Substitute into the formula to calculate the required illumination duration t0. For example, if the target light dose d0 is 60 J / cm 2 , optical power density parameter P d 30.1mW / cm 2 , the light dose efficiency parameter η is 0.9, then the calculated illumination duration t0 is approximately 2219 seconds (i.e., approximately 37 minutes).

[0068] In step S200, the illumination duration is corrected for light dose based on tissue light transmission parameters to obtain the corrected illumination duration, including: using tissue light transmission parameters to calculate the deep light transmission rate and surface light transmission rate of nasal tissue, inputting the deep light transmission rate into a preset layered light transmission model for integral calculation to obtain deep dose distribution parameters; and using a light scattering correction method to quantitatively process the surface light transmission rate to obtain surface dose distribution parameters.

[0069] The transmission of light in the nasal tissue is evaluated by tissue light transmission parameters; specifically, the dose distribution parameters of the deep and surface layers are calculated using the deep light transmission rate and the surface light transmission rate.

[0070] For example, if the tissue light transmission parameter P t 49.95mW / cm 2 , calculated by the layered light transmission model, the deep light transmission rate is 70%, and the surface light transmission rate is 30%. The corresponding deep and surface dose distribution parameters are 34.965mW / cm 2 and 14.985mW / cm 2 .

[0071] The illumination duration is corrected according to the deep dose distribution parameters to obtain a preliminary correction duration, and the preliminary correction duration is adjusted according to the surface dose distribution parameters to obtain a correction factor.

[0072] By adjusting the initial correction duration, it is ensured that the light dose of different layers of tissue meets the treatment requirements; specifically, the dose distribution parameters of the deep and surface layers are used to correct the illumination duration in stages and calculate the correction factor.

[0073] For example, if the initial correction time is 30 minutes, the deep dose distribution parameters require a 10% extension of the illumination time, and the surface dose distribution parameters require a 5% shortening of the illumination time, then the final correction factor comprehensive result is a 5% extension of the illumination time, that is, the adjusted time is 31.5 minutes.

[0074] The correction factor and the illumination duration are compounded to obtain the corrected illumination duration.

[0075] The final corrected illumination duration is obtained by comprehensively calculating the correction factor and the initially calculated illumination duration; specifically, the two time parameters are combined and adjusted to ensure that the illumination time meets the treatment requirements.

[0076] For example, the initially calculated illumination time is 37 minutes, and the correction factor requires an extension of 5%, so the corrected illumination time is approximately 38.85 minutes.

[0077] Among them, the step of adjusting the initial correction time according to the surface dose distribution parameters to obtain the correction factor includes: calculating the light energy absorption efficiency and treatment safety parameters of the surface of the nasal tissue according to the surface dose distribution parameters, and generating a comprehensive treatment adjustment factor based on the light energy absorption efficiency and treatment safety parameters.

[0078] The surface light energy absorption efficiency and treatment safety are calculated through the surface dose distribution parameters; specifically, the light energy absorption efficiency and treatment safety parameters are used to generate a comprehensive treatment adjustment factor.

[0079] For example, if the surface light energy absorption efficiency is 85% and the treatment safety parameter is 90%, the comprehensive treatment adjustment factor is 0.85×0.90=0.765.

[0080] The initial correction duration is adjusted according to the comprehensive treatment adjustment factor to obtain the correction factor.

[0081] The initial correction time is finally adjusted through the comprehensive treatment adjustment factor to obtain the correction factor; specifically, the initial correction time is corrected according to the calculated adjustment factor to ensure safe and effective treatment.

[0082] For example, if the initial correction time is 37 minutes and the comprehensive treatment adjustment factor is 0.765, the final correction factor is 37×0.765≈28.305 minutes.

[0083] In step S300, the light power density parameter and the corrected illumination duration are used to set the luminous intensity, wavelength and illumination time of the LED illumination light source, and the patient's nasal tissue is illuminated by the set LED illumination light source.

[0084] Through the control module, the relevant parameters of the LED illumination light source are set according to the light power density parameters and the corrected illumination duration; specifically, the control module adjusts the current and voltage of the LED light source to achieve the required luminous intensity and wavelength, and sets the illumination time according to the corrected illumination duration.

[0085] For example, if the light power density parameter requires a higher luminous intensity, the control module increases the current of the LED light source to improve the brightness, and accurately sets the irradiation time according to the corrected illumination duration to ensure the treatment effect.

[0086] In this embodiment, by integrating the collection of real-time physiological data and the accurate calculation of light absorption characteristics, the irradiation parameters of the LED light source can be dynamically adjusted to ensure that the light power density and irradiation duration of each treatment can be optimized according to the actual situation of the patient, thereby improving the pertinence and effectiveness of the treatment. Specifically, the temperature, humidity and blood oxygen data of the patient's internal nasal tissue are obtained in real time through the sensor module, and these real-time physiological data are used to calculate the light absorption characteristics of the nasal tissue. Then, these characteristics are used to analyze the absorbance and transmittance to obtain accurate light power density parameters and tissue light transmittance parameters.

[0087] When analyzing temperature and humidity data, the light absorption characteristics are accurately calculated by comprehensively evaluating the wetness and congestion of the nasal mucosa and combining it with blood oxygen data. These characteristic data are then substituted into the preset calculation formula to obtain the absorbance and transmittance of light of different wavelengths, which are further converted into light power density parameters and tissue light transmittance parameters for dynamically adjusting the luminous intensity and irradiation time of the LED light source.

[0088] By correcting the duration of illumination, it is ensured that both deep and surface tissues receive effective light doses. Finally, through the control module, the luminous intensity, wavelength and irradiation time of the LED light source are accurately set to achieve effective irradiation of the patient's nasal tissue. This method not only improves the treatment effect, but also shortens the course of treatment. At the same time, it is powered by the TYPE-C charging port, making the device more portable and easy to use.

[0089] Embodiment 3:

[0090] like Figure 2 As shown, the present application also provides a control system 10 of an LED light source rhinitis therapeutic device. The LED light source rhinitis therapeutic device uses a TYPE-C charging port and includes an acquisition unit 11, a correction unit 12 and a control unit 13.

[0091] The acquisition unit 11 is mainly used to acquire real-time physiological data of the patient's internal nasal tissue, determine the light absorption characteristics of the nasal tissue based on the real-time physiological data, perform absorbance and transmittance analysis on the light absorption characteristics, and obtain light power density parameters and tissue light transmittance parameters.

[0092] The correction unit 12 is mainly used to calculate the corresponding illumination duration using the light power density parameter, and perform light dosage correction on the illumination duration based on the tissue light transmission parameter to obtain the corrected illumination duration.

[0093] The control unit 13 is mainly used to control the LED irradiation light source of the LED light source rhinitis therapeutic device through the light power density parameter and the corrected illumination duration.

[0094] In this embodiment, the acquisition unit 11 is used to acquire the temperature, humidity and blood oxygen saturation data of the patient's nasal cavity internal tissue in real time, and these real-time physiological data are used to determine the light absorption characteristics of the nasal tissue, and its absorbance and transmittance are analyzed in detail to obtain accurate light power density parameters and tissue light transmission parameters. The correction unit 12 uses these parameters to calculate the required illumination duration, and corrects the light dose based on the tissue light transmission parameters to ensure that the corrected illumination duration can be effectively adjusted according to the individual differences of different patients. Finally, the control unit 13 is used to accurately control the LED irradiation light source of the LED light source rhinitis treatment device, and the luminous intensity, wavelength and irradiation time of the LED light source are adjusted according to the light power density parameters and the corrected illumination duration to ensure the optimization of the treatment effect.

[0095] It should be noted that technical personnel in the relevant technical field can clearly understand that, for the convenience and conciseness of description, the specific working process of the system and each unit described above can refer to the corresponding process in the aforementioned control method embodiment of the LED light source rhinitis therapeutic device, and will not be repeated here.

[0096] As described above, the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features thereof may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A control method for an LED light source rhinitis therapeutic device, wherein the LED light source rhinitis therapeutic device uses a TYPE-C charging port, characterized in that: include: Acquire real-time physiological data of the patient's internal nasal tissue, determine the light absorption characteristics of the nasal tissue according to the real-time physiological data, perform absorbance and transmittance analysis on the light absorption characteristics, and obtain light power density parameters and tissue light transmittance parameters; Calculating a corresponding illumination duration using the optical power density parameter, and performing light dosage correction on the illumination duration based on the tissue light transmission parameter to obtain a corrected illumination duration; The LED irradiation light source of the LED light source rhinitis therapeutic device is controlled by the light power density parameter and the corrected illumination duration.

2. The control method of the LED light source rhinitis therapeutic device according to claim 1, characterized in that: The step of obtaining real-time physiological data of the patient's internal nasal tissue and determining the light absorption characteristics of the nasal tissue according to the real-time physiological data includes: The temperature, humidity and blood oxygen saturation of the internal tissue of the nasal cavity are detected by a preset physiological data acquisition module to obtain real-time physiological data; wherein the real-time physiological data includes temperature data, humidity data and blood oxygen data; Analyze the physiological condition of the nasal mucosa using the temperature data and humidity data to obtain a mucosal wetness parameter and a mucosal congestion degree parameter; The mucosal wetness parameter and the mucosal congestion degree parameter are combined with the blood oxygen data to obtain light absorption characteristics.

3. The control method of the LED light source rhinitis therapeutic device according to claim 2, characterized in that: The step of analyzing the absorbance and transmittance of the light absorption characteristics to obtain light power density parameters and tissue light transmittance parameters includes: Calculate the absorbance and transmittance of the light absorption characteristic to light of different wavelengths; wherein the calculation formula for calculating the absorbance and transmittance of the light absorption characteristic to light of different wavelengths is as follows: Where A(λ) is the absorbance at wavelength λ, I0(λ) is the incident light intensity, I(λ) is the transmitted light intensity, and T(λ) is the transmittance at wavelength λ; The calculation formula for calculating the optical power density parameter and the tissue light transmission parameter using the absorbance and the transmittance is as follows: Among them, P t is the tissue light transmission parameter, P d is the optical power density parameter, P0 is the initial optical power, and S is the spot area.

4. The control method of the LED light source rhinitis therapeutic device according to claim 1, characterized in that: The calculation formula for calculating the corresponding illumination duration using the optical power density parameter is as follows: Among them, t0 is the illumination duration, D0 is the target light dose, P d is the light power density parameter, and η is the light dose efficiency parameter.

5. The control method of the LED light source rhinitis therapeutic device according to claim 1, characterized in that: The step of performing light dosage correction on the illumination duration based on the tissue light transmission parameter to obtain a corrected illumination duration comprises: The deep layer light transmission rate and the surface layer light transmission rate of the nasal tissue are calculated by using the tissue light transmission parameters, and the deep layer light transmission rate is input into a preset layered light transmission model for integral calculation to obtain a deep layer dose distribution parameter; the surface layer light transmission rate is quantitatively processed by using a light scattering correction method to obtain a surface layer dose distribution parameter; The illumination duration is corrected according to the deep dose distribution parameter to obtain a preliminary correction duration, and the preliminary correction duration is adjusted according to the surface dose distribution parameter to obtain a correction factor; The correction factor and the illumination duration are compound calculated to obtain the corrected illumination duration.

6. The control method of the LED light source rhinitis therapeutic device according to claim 5, characterized in that: The step of adjusting the preliminary correction time according to the surface dose distribution parameter to obtain a correction factor comprises: Calculating the light energy absorption efficiency and treatment safety parameters of the surface layer of the nasal tissue according to the surface dose distribution parameters, and generating a comprehensive treatment adjustment factor based on the light energy absorption efficiency and treatment safety parameters; The initial correction duration is adjusted according to the comprehensive treatment adjustment factor to obtain a correction factor.

7. The control method of the LED light source rhinitis therapeutic device according to claim 1, characterized in that: The step of controlling the LED irradiation light source of the LED light source rhinitis therapeutic device by using the light power density parameter and the corrected illumination duration includes: The light power density parameter and the corrected illumination duration are used to set the luminous intensity, wavelength and illumination time of the LED illumination light source, and the patient's nasal tissue is illuminated using the set LED illumination light source.

8. A control system for an LED light source rhinitis therapeutic device, the LED light source rhinitis therapeutic device uses a TYPE-C charging port, characterized in that: include: An acquisition unit is used to acquire real-time physiological data of the patient's internal nasal tissue, determine the light absorption characteristics of the nasal tissue according to the real-time physiological data, perform absorbance and transmittance analysis on the light absorption characteristics, and obtain light power density parameters and tissue light transmittance parameters; a correction unit, configured to calculate a corresponding illumination duration using the optical power density parameter, and perform light dose correction on the illumination duration based on the tissue light transmission parameter to obtain a corrected illumination duration; A control unit is used to control the LED irradiation light source of the LED light source rhinitis therapeutic device through the optical power density parameter and the corrected illumination duration.

Images